Table 2.
Comparison of renal function between two groups of patients before and after treatment
|
Parameter
|
Time
|
CM group (n = 107)
|
CSCT group (n = 104)
|
t
|
P value
|
| Serum creatinine (mg/dL) | Baseline | 1.04 ± 0.32 | 1.04 ± 0.29 | 0.122 | 0.903 |
| 6 months | 1.05 ± 0.35 | 1.06 ± 0.31 | 0.265 | 0.791 | |
| GFR (mL/minute/1.73 m2) | Baseline | 50.83 ± 5.01 | 50.92 ± 5.19 | 0.126 | 0.900 |
| 6 months | 50.13 ± 4.61 | 50.52 ± 4.87 | 0.603 | 0.547 | |
| ACR (mg/g) | Baseline | 211.51 ± 30.11 | 207.54 ± 30.15 | 0.956 | 0.340 |
| 6 months | 158.11 ± 28.85 | 145.87 ± 29.23 | 3.062 | 0.002 |
GFR: Glomerular filtration rate; ACR: Albumin/creatinine ratio; CM: Canagliflozin monotherapy; CSCT: Canagliflozin and semaglutide combination therapy.